retatrutide triple agonist obesity trial π¨ TRIUMPH-1 Phase 3 top-line results, much awaited and just announced β¬οΈ 28.3% Weight loss at 80 weeks β¬οΈ 30.3% weight loss at 104 weeks among adults with baseline BMI >35 π¨ HOT OFF THE PRESS:
Pay in 4 interest-free payments of $5.70 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Sep 26 - Oct 1









![Cardiovascular disease continuum-GLP-1 action. Adapted from [46]](https://www.researchgate.net/publication/357072789/figure/fig1/AS:1146405179654167@1650335702879/Cardiovascular-disease-continuum-GLP-1-action-Adapted-from-46.png)
















